Drug Profile
Research programme: antiviral therapeutics - Zirus/Emory University
Alternative Names: Gene trap platform - ZirusLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Emory University; Zirus
- Class Small molecules
- Mechanism of Action Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Viral-infections in USA
- 30 Mar 2010 Zirus and Emory University form a collaboration and research agreement to develop small-molecule antiviral compounds
- 08 Oct 2009 Early research in Viral infections in USA (unspecified route)